Cencora Inc. Asset Resilience Ratio
Cencora Inc. asset resilience ratio. Cencora Inc. (COR) has an Asset Resilience Ratio of 2.24% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See COR cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Cencora Inc. (2006–2025)
Asset resilience ratio of Cencora Inc. from 2006 to 2025. This chart shows how Cencora Inc.'s Asset Resilience Ratio has changed over time. Read Cencora Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Cencora Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see COR asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.75 Billion | 2.24% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $1.75 Billion | 2.24% |
Asset Resilience Insights
- Limited Liquidity: Cencora Inc. maintains only 2.24% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Cencora Inc. Industry Peers by Asset Resilience Ratio
Compare Cencora Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SINOPHARM GROUP 1/5/O.N.
F:X2S1 |
Medical Distribution | 0.00% |
|
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IS:SELEC |
Medical Distribution | 7.12% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
Cencora Inc. Asset Resilience Ratio by Year (2006–2025)
Cencora Inc. asset resilience ratio by year from 2006 to 2025. The table below shows the annual Asset Resilience Ratio data for Cencora Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 5.69% | $4.36 Billion | $76.59 Billion | +1.02pp |
| 2024-09-30 | 4.67% | $3.13 Billion | $67.10 Billion | +0.53pp |
| 2023-09-30 | 4.14% | $2.59 Billion | $62.56 Billion | -1.85pp |
| 2022-09-30 | 5.99% | $3.39 Billion | $56.56 Billion | +0.90pp |
| 2021-09-30 | 5.09% | $2.92 Billion | $57.34 Billion | -5.29pp |
| 2020-09-30 | 10.38% | $4.60 Billion | $44.27 Billion | +10.31pp |
| 2016-09-30 | 0.08% | $26.10 Million | $33.59 Billion | -0.11pp |
| 2015-09-30 | 0.18% | $50.80 Million | $27.74 Billion | -3.61pp |
| 2007-09-30 | 3.80% | $467.42 Million | $12.31 Billion | +3.27pp |
| 2006-09-30 | 0.53% | $67.84 Million | $12.78 Billion | -- |
About Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order … Read more